洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

【ChiCTR2100052120】The effect of educational intervention on knowledge level of cervical cancer and screening, screening intention and Pap test uptake among Chinese immigrant women: A pilot study.

基本信息
登记号

ChiCTR2100052120

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-10-19

临床申请受理号

/

靶点

/

适应症

Cervical cancer

试验通俗题目

The effect of educational intervention on knowledge level of cervical cancer and screening, screening intention and Pap test uptake among Chinese immigrant women: A pilot study.

试验专业题目

The effect of educational intervention on knowledge level of cervical cancer and screening, screening intention and Pap test uptake among Chinese immigrant women: A pilot study.

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

1. To develop an evidence-based educational intervention with navigation assistance for Chinese immigrant women. 2. To develop a training programme for Chinese LHWs and evaluate its effect on improving knowledge and competency of taking up the role of LHWs. 3. To evaluate the feasibility and acceptability of an evidence-based educational intervention with navigation assistance among Chinese immigrant women. 4. To preliminarily evaluate the effect of an evidence-based educational intervention on knowledge level of cervical cancer and screening, cervical cancer screening intention and Pap test uptake among Chinese immigrant women.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

Randomization allocation will be performed by a computer-generated random schedule (www.randomization.com). The study uses block randomization with a block size of four and a 1:1 allocation. Then, an independent statistician will get the random number. The group assignment number card will be put into opaque sealed

盲法

Blinding lay health workers is not possible because they know when they deliver the intervention due to the group allocation. Research assistant 1 who helps to recruit participants, collect baseline data at T0 (T0, before randomization), and allocate participants randomly will not be blinded. Research assistant 2 who collect data at 1 month after a health talk before 1st telephone follow up (T1) and after 3 months post intervention received by intervention group (T2) will be blinded to participants allocation.

试验项目经费来源

Nil

试验范围

/

目标入组人数

40

实际入组人数

/

第一例入组时间

2021-09-05

试验终止时间

2022-12-31

是否属于一致性

/

入选标准

To be included in the study, the inclusion criteria are Chinese immigrants aged 25 years or older who have a history of sexual activity, have not attend cervical cancer screening in the past 3 years; reside in Hong Kong less than 7 years, have not been previously diagnosed with cervical cancer; have not attend any intervention or educational programme related to cervical cancer screening within 1 year; and are able to communicate in Mandarin or Cantonese and read Traditional or Simplified Chinese.;

排除标准

The exclusion criteria are women whose origin is not Mainland; are mentally unfit and cannot give valid consent.;

研究者信息
研究负责人姓名
请登录查看
试验机构

Nil

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Nil的其他临床试验

香港中文大學的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

全球药物研发中心
全球研发数据与行业前沿情报

383,318
全球在研药物数
964
本月临床试验数
全球批准的新药
更多
全球首批
各国首批
数据来源:摩熵医药
更新时间:
研发动态
相关报告
政策法规
更多信息,请进入全球药物研发中心查看

医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

2,630亿元
2026年Q2总销售额
6.14%(2026Q2)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
更多信息,请进入医药市场洞察中心查看